We are happy to share that Nathalie Maubon, PhD, our CEO/CSO is currently attending BioAsia Taiwan, organized in Taipei. The event aims at building on the success of recent years’ gatherings to bring together biotechnology and pharmaceutical executives and investors from North America, Europe and Asia, and explore business opportunities and to engage with Taiwan’s emerging biotech sector. This year’s theme, “Embracing Asian Dynamics“, will showcase the great opportunities that exist within Asian’s economies, its dynamic and innovation-generating biomedical ecosystems, and its globally-connected bio-industry production and value chains.
On this occasion, Nathalie will participate tomorrow (07/27, from 13:30 to 17:00) in a Focus symposium entitled “Pushing Frontiers in Drug Screening: Innovations in Human iPSC Technology, 3D Culture Models, and High-Throughput Screening for Accelerated Drug Discovery”. Co-organized with LumiSTAR Biotechnology (Taiwan) and Molecular Devices (USA), this symposium will allow the attendees to know more about cutting-edge technologies for high-throughput phenotypic screening. Nathalie will focus her talk about BIOMIMESYS® Hydroscaffold, our ready-to-use organ-specific extracellular matrix for a relevant and predictive phenotypic screening.
For more information about this Focus symposium, please find the detailed programme here. The symposium will be held in Room 403, Nangang International Exhibition Center, Hall1 (TaiNEX 1) / No.1, Jingmao 2nd Rd., Nangang District, Taipei City (南港展覽館一館4樓403會議室). Still time to register here!
Thanks to the organizers of BioAsia to give us this opportunity, and to our partners for arranging this symposium with us. Nathalie is glad nice to meet Yu-Fen Chang, CEO, LumiSTAR Biotechnology (Taiwan) and Angeline Lim, Senior Applications Scientist, Molecular Devices (USA) on this occasion!